Back to Search Start Over

GRIN Therapeutics Announces Initiation of Astroscape Clinical Trial of Radiprodil for Treatment of Tuberous Sclerosis Complex and Focal Cortical Dysplasia Type II

Source :
PR Newswire. October 8, 2024
Publication Year :
2024

Abstract

Dosing of patients in the second clinical research program for radiprodil follows recent announcement of positive topline data from the Honeycomb trial in GRIN-related neurodevelopmental disorder; radiprodil appeared generally well-tolerated [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PR Newswire
Publication Type :
News
Accession number :
edsgcl.811509667